KR100748293B1 - Ｔｎｆ/ｎｇｆ 수용체 페밀리와 다른 단백질의 수용체의기능조절물질 - Google Patents

Ｔｎｆ/ｎｇｆ 수용체 페밀리와 다른 단백질의 수용체의기능조절물질 Download PDF

Info

Publication number
KR100748293B1
KR100748293B1 KR1020057019204A KR20057019204A KR100748293B1 KR 100748293 B1 KR100748293 B1 KR 100748293B1 KR 1020057019204 A KR1020057019204 A KR 1020057019204A KR 20057019204 A KR20057019204 A KR 20057019204A KR 100748293 B1 KR100748293 B1 KR 100748293B1
Authority
KR
South Korea
Prior art keywords
rap
protein
rip
proteins
binding
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
KR1020057019204A
Other languages
English (en)
Korean (ko)
Other versions
KR20050107527A (ko
Inventor
데이비드 왈라치
안드레이 코발레코
Original Assignee
예다 리서치 앤드 디벨럽먼트 캄파니 리미티드
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from IL12375898A external-priority patent/IL123758A0/xx
Application filed by 예다 리서치 앤드 디벨럽먼트 캄파니 리미티드 filed Critical 예다 리서치 앤드 디벨럽먼트 캄파니 리미티드
Publication of KR20050107527A publication Critical patent/KR20050107527A/ko
Application granted granted Critical
Publication of KR100748293B1 publication Critical patent/KR100748293B1/ko
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Images

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4702—Regulators; Modulating activity
    • C07K14/4703—Inhibitors; Suppressors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Zoology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Toxicology (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Virology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Pain & Pain Management (AREA)
  • Physics & Mathematics (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Plant Pathology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Microbiology (AREA)
  • AIDS & HIV (AREA)
  • Rheumatology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
KR1020057019204A 1998-03-19 1999-03-18 Ｔｎｆ/ｎｇｆ 수용체 페밀리와 다른 단백질의 수용체의기능조절물질 Expired - Fee Related KR100748293B1 (ko)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
IL123758 1998-03-19
IL12375898A IL123758A0 (en) 1998-03-19 1998-03-19 Modulators of the function of receptors of the TNF/NGF receptor family and other proteins
IL126024 1998-09-01
IL12602498A IL126024A0 (en) 1998-03-19 1998-09-01 Modulators of the function of receptors of the tnf/ngf receptor family and other proteins
CA002323637A CA2323637A1 (en) 1998-03-19 1999-03-18 Modulators of the function of receptors of the tnf/ngf receptor family and other proteins

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
KR1020007009953A Division KR100693677B1 (ko) 1998-03-19 1999-03-18 Ｔｎｆ/ｎｇｆ 수용체 페밀리와 다른 단백질의 수용체의기능조절물질

Publications (2)

Publication Number Publication Date
KR20050107527A KR20050107527A (ko) 2005-11-11
KR100748293B1 true KR100748293B1 (ko) 2007-08-09

Family

ID=39598416

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020057019204A Expired - Fee Related KR100748293B1 (ko) 1998-03-19 1999-03-18 Ｔｎｆ/ｎｇｆ 수용체 페밀리와 다른 단백질의 수용체의기능조절물질

Country Status (23)

Country Link
US (1) US6734174B1 (enExample)
EP (1) EP1062336B1 (enExample)
JP (1) JP4351389B2 (enExample)
KR (1) KR100748293B1 (enExample)
CN (1) CN1232641C (enExample)
AT (1) ATE318310T1 (enExample)
AU (1) AU760900B2 (enExample)
BG (2) BG64990B1 (enExample)
BR (1) BR9909659A (enExample)
CA (2) CA2323637A1 (enExample)
DE (1) DE69929958T2 (enExample)
DK (1) DK1062336T3 (enExample)
EA (1) EA004062B1 (enExample)
EE (1) EE200000538A (enExample)
ES (1) ES2258838T3 (enExample)
HU (1) HUP0101612A3 (enExample)
IL (1) IL126024A0 (enExample)
NO (1) NO327854B1 (enExample)
NZ (2) NZ506776A (enExample)
PL (1) PL200763B1 (enExample)
PT (1) PT1062336E (enExample)
SK (1) SK285804B6 (enExample)
WO (1) WO1999047672A1 (enExample)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2011049350A3 (ko) * 2009-10-19 2011-10-13 한올바이오파마주식회사 변형된 인간 종양 괴사 인자 수용체-1 폴리펩티드 또는 그의 절편 및 그의 제조방법

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7189832B1 (en) * 1998-08-20 2007-03-13 The Regents Of The University Of California Gamma subunit of cytokine responsive IκB-alpha kinase complex and methods of using same
US7745579B1 (en) 1998-09-01 2010-06-29 David Wallach Inhibitor of NF-KB activation
TR201809678T4 (tr) 2001-06-26 2018-07-23 Amgen Fremont Inc Opgl ye karşi antikorlar.
US7521534B1 (en) * 2003-03-03 2009-04-21 The University Board Of Regents Of Texas System IKK gamma gene products and methods for making and using same
BRPI0414714A (pt) * 2003-09-24 2006-11-21 Pasteur Institut polinucleotìdeo purificado, vetor, célula hospedeira, construto de fusão de polipeptìdeo, métodos de inibir a rota de sinalização de nf-capab, de interromper a oligomerização de nemo, e, de identificar polipeptìdeos que modulam a oligomerização de nemo, e, uso de uma quantidade eficaz de uma composição
CN102399819B (zh) * 2011-08-24 2013-06-19 西北农林科技大学 一种质粒型腺病毒载体pAd-NRIP1及其构建方法
DE102011115480A1 (de) * 2011-10-06 2013-04-11 Biostep Gmbh Substrat und Vorrichtung zur Chemilumineszenzdetektion
WO2016094846A1 (en) 2014-12-11 2016-06-16 President And Fellows Of Harvard College Inhibitors of cellular necrosis and related methods

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1996025941A1 (en) * 1995-02-22 1996-08-29 Yeda Research And Development Co. Ltd. Modulators of regulatory proteins
WO1996036730A1 (en) * 1995-05-18 1996-11-21 President And Fellows Of Harvard College Cell death protein

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL73883A (en) * 1984-12-20 1990-12-23 Yeda Res & Dev Monoclonal antibodies against tnf-alpha,hybridomas producing them and method for the purification of tnf-alpha
IL94039A (en) * 1989-08-06 2006-09-05 Yeda Res & Dev Antibodies to tbp - 1 and their use
AU636608B2 (en) * 1989-05-18 1993-05-06 Yeda Research And Development Co. Ltd. Tumor necrosis factor binding protein II, it's purification and antibodies thereto
AU7457796A (en) 1995-10-23 1997-05-15 Tularik Inc. Rip: novel human protein involved in tumor necrosis factor signal transduction, and screening assays
AU3228197A (en) * 1996-05-29 1998-01-05 Genzyme Corporation Cell growth regulatory genes

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1996025941A1 (en) * 1995-02-22 1996-08-29 Yeda Research And Development Co. Ltd. Modulators of regulatory proteins
WO1996036730A1 (en) * 1995-05-18 1996-11-21 President And Fellows Of Harvard College Cell death protein

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2011049350A3 (ko) * 2009-10-19 2011-10-13 한올바이오파마주식회사 변형된 인간 종양 괴사 인자 수용체-1 폴리펩티드 또는 그의 절편 및 그의 제조방법
US9068019B2 (en) 2009-10-19 2015-06-30 Hanall Biopharma Co., Ltd. Modified human tumor necrosis factor receptor-1 polypeptide or fragment thereof, and method for preparing same

Also Published As

Publication number Publication date
EE200000538A (et) 2002-04-15
EP1062336A1 (en) 2000-12-27
DK1062336T3 (da) 2006-05-29
US6734174B1 (en) 2004-05-11
BG104769A (en) 2001-04-30
NO20004649D0 (no) 2000-09-18
JP4351389B2 (ja) 2009-10-28
JP2002506644A (ja) 2002-03-05
HUP0101612A2 (hu) 2004-01-28
KR20050107527A (ko) 2005-11-11
EP1062336B1 (en) 2006-02-22
BR9909659A (pt) 2000-11-21
CA2625284A1 (en) 1999-09-23
AU2954599A (en) 1999-10-11
NZ506776A (en) 2003-08-29
PT1062336E (pt) 2006-05-31
BG64990B1 (bg) 2006-11-30
AU760900B2 (en) 2003-05-22
WO1999047672A1 (en) 1999-09-23
SK13762000A3 (sk) 2001-03-12
IL126024A0 (en) 1999-05-09
NO20004649L (no) 2000-10-30
DE69929958D1 (de) 2006-04-27
ATE318310T1 (de) 2006-03-15
CN1295614A (zh) 2001-05-16
BG65684B1 (bg) 2009-06-30
DE69929958T2 (de) 2006-11-23
HUP0101612A3 (en) 2005-03-29
ES2258838T3 (es) 2006-09-01
CN1232641C (zh) 2005-12-21
EA004062B1 (ru) 2003-12-25
NO327854B1 (no) 2009-10-05
HK1034995A1 (en) 2001-11-09
EA200000961A1 (ru) 2001-04-23
SK285804B6 (sk) 2007-08-02
PL343262A1 (en) 2001-07-30
NZ525566A (en) 2004-12-24
CA2323637A1 (en) 1999-09-23
BG109537A (en) 2007-11-30
PL200763B1 (pl) 2009-02-27

Similar Documents

Publication Publication Date Title
US8236507B2 (en) Modulators of TNF receptor associated factor (TRAF), their preparation and use
EP2042509B1 (en) Modulators of the function of FAS receptors and other proteins
US20080159986A1 (en) Modulators of the functions of receptors of the tnf/ngf receptor family and other proteins
IL109632A (en) Modulators of the function of tnf receptors
EP1062336B1 (en) Modulators of the function of receptors of the tnf/ngf receptor family
BG64799B1 (bg) Саsн (хомолог на каспаза) със смъртоносен ефекторен домен и модулатори на функцията на fаs рецептори
KR100693677B1 (ko) Ｔｎｆ/ｎｇｆ 수용체 페밀리와 다른 단백질의 수용체의기능조절물질
AU2003200969B2 (en) Modulators of the function of receptors of the TNF/NGF receptor family and other proteins
US20050013816A1 (en) Modulators of the function of FAS/AP01 receptors
CN100557021C (zh) Tnf/ngf受体家族和其它蛋白质的受体的功能的调节剂
AU767967B2 (en) Modulators of TNF receptor associated factor (TRAF), their preparation and use
MXPA00009138A (en) Modulators of the function of receptors of the tnf/ngf receptor family and other proteins
MXPA99008574A (en) Modulators of the function of receptors of the tnf/ngf receptor family
CZ20003421A3 (cs) DNA sekvence kódující protein asociovaný s RIP, protein kódovaný touto sekvencí a způsoby jeho použití
IL112692A (en) ANTIBODIES TO PROTEIN WHICH BINDS TO Fas-R

Legal Events

Date Code Title Description
A107 Divisional application of patent
A201 Request for examination
PA0104 Divisional application for international application

St.27 status event code: A-0-1-A10-A16-div-PA0104

St.27 status event code: A-0-1-A10-A18-div-PA0104

PA0201 Request for examination

St.27 status event code: A-1-2-D10-D11-exm-PA0201

PG1501 Laying open of application

St.27 status event code: A-1-1-Q10-Q12-nap-PG1501

E902 Notification of reason for refusal
PE0902 Notice of grounds for rejection

St.27 status event code: A-1-2-D10-D21-exm-PE0902

T11-X000 Administrative time limit extension requested

St.27 status event code: U-3-3-T10-T11-oth-X000

R17-X000 Change to representative recorded

St.27 status event code: A-3-3-R10-R17-oth-X000

AMND Amendment
E13-X000 Pre-grant limitation requested

St.27 status event code: A-2-3-E10-E13-lim-X000

P11-X000 Amendment of application requested

St.27 status event code: A-2-2-P10-P11-nap-X000

P13-X000 Application amended

St.27 status event code: A-2-2-P10-P13-nap-X000

E902 Notification of reason for refusal
PE0902 Notice of grounds for rejection

St.27 status event code: A-1-2-D10-D21-exm-PE0902

T11-X000 Administrative time limit extension requested

St.27 status event code: U-3-3-T10-T11-oth-X000

AMND Amendment
P11-X000 Amendment of application requested

St.27 status event code: A-2-2-P10-P11-nap-X000

P13-X000 Application amended

St.27 status event code: A-2-2-P10-P13-nap-X000

E601 Decision to refuse application
PE0601 Decision on rejection of patent

St.27 status event code: N-2-6-B10-B15-exm-PE0601

T11-X000 Administrative time limit extension requested

St.27 status event code: U-3-3-T10-T11-oth-X000

J201 Request for trial against refusal decision
PJ0201 Trial against decision of rejection

St.27 status event code: A-3-3-V10-V11-apl-PJ0201

AMND Amendment
E13-X000 Pre-grant limitation requested

St.27 status event code: A-2-3-E10-E13-lim-X000

P11-X000 Amendment of application requested

St.27 status event code: A-2-2-P10-P11-nap-X000

P13-X000 Application amended

St.27 status event code: A-2-2-P10-P13-nap-X000

PB0901 Examination by re-examination before a trial

St.27 status event code: A-6-3-E10-E12-rex-PB0901

B701 Decision to grant
PB0701 Decision of registration after re-examination before a trial

St.27 status event code: A-3-4-F10-F13-rex-PB0701

GRNT Written decision to grant
PR0701 Registration of establishment

St.27 status event code: A-2-4-F10-F11-exm-PR0701

PR1002 Payment of registration fee

Fee payment year number: 1

St.27 status event code: A-2-2-U10-U12-oth-PR1002

PG1601 Publication of registration

St.27 status event code: A-4-4-Q10-Q13-nap-PG1601

LAPS Lapse due to unpaid annual fee
PC1903 Unpaid annual fee

Not in force date: 20100804

Payment event data comment text: Termination Category : DEFAULT_OF_REGISTRATION_FEE

St.27 status event code: A-4-4-U10-U13-oth-PC1903

PC1903 Unpaid annual fee

Ip right cessation event data comment text: Termination Category : DEFAULT_OF_REGISTRATION_FEE

Not in force date: 20100804

St.27 status event code: N-4-6-H10-H13-oth-PC1903

R18-X000 Changes to party contact information recorded

St.27 status event code: A-5-5-R10-R18-oth-X000

R18-X000 Changes to party contact information recorded

St.27 status event code: A-5-5-R10-R18-oth-X000